Copyright
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Nephrol. Dec 25, 2024; 13(4): 100087
Published online Dec 25, 2024. doi: 10.5527/wjn.v13.i4.100087
Published online Dec 25, 2024. doi: 10.5527/wjn.v13.i4.100087
Patterns of kidney diseases diagnosed by kidney biopsy and the impact of the COVID-19 pandemic in Yogyakarta, Indonesia: A single-center study
Metalia Puspitasari, Yulia Wardhani, Prenali Dwisthi Sattwika, Wynne Wijaya, Department of Internal Medicine, Universitas Gadjah Mada, Yogyakarta 55281, Indonesia
Prenali Dwisthi Sattwika, Clinical Epidemiology and Biostatistics Unit, Universitas Gadjah Mada, Yogyakarta 55281, Indonesia
Prenali Dwisthi Sattwika, Radcliffe Department of Medicine, University of Oxford, Oxford OX39DU, Oxfordshire, United Kingdom
Wynne Wijaya, Department of Oncology, University of Oxford, Oxford OX37DQ, Oxfordshire, United Kingdom
Co-corresponding authors: Metalia Puspitasari and Wynne Wijaya.
Author contributions: Puspitasari M was responsible for conceptualization, methodology, investigation, supervision, writing, review, editing, and project administration; Wardhani Y was responsible for data curation, resources, supervision, and project administration; Sattwika PD was responsible for conceptualization, methodology, visualization, formal analysis, writing, review, and editing; Wijaya W was responsible for conceptualization, data curation, investigation, methodology, formal analysis, writing, original draft, writing, review, and editing; all of the authors read and approved the final version of the manuscript to be published.
Institutional review board statement: This study was conducted according to the World Medical Association Declaration of Helsinki and has been approved by the ethical committee of the institution, No. KE/FK/1902/EC/2003.
Informed consent statement: Not applicable since secondary data was used in this study.
Conflict-of-interest statement: The authors have no conflicts of interest to declare.
Data sharing statement: The data that support the findings of this study are available from the corresponding author, Puspitasari M, upon reasonable request.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Metalia Puspitasari, Doctor, MD, MSc, Consultant Physician-Scientist, Doctor, Researcher, Senior Lecturer, Department of Internal Medicine, Universitas Gadjah Mada, Jln. Farmako, Yogyakarta 55281, Indonesia. metaliapuspitasari@ugm.ac.id
Received: August 6, 2024
Revised: September 25, 2024
Accepted: October 20, 2024
Published online: December 25, 2024
Processing time: 92 Days and 14.1 Hours
Revised: September 25, 2024
Accepted: October 20, 2024
Published online: December 25, 2024
Processing time: 92 Days and 14.1 Hours
Core Tip
Core Tip: This study retrospectively reviewed the demographic, histopathologic, clinical, and laboratory data of adult patients with biopsy-proven kidney diseases from 2017 to 2022. Different kidney disease patterns were observed in different sex, age categories, clinical syndromes, and biopsy dates relative to the coronavirus disease 2019 pandemic.